BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2696799)

  • 1. Intravitreal drug therapy.
    Peyman GA; Schulman JA
    Jpn J Ophthalmol; 1989; 33(4):392-404. PubMed ID: 2696799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffusion and pharmacokinetics of antibiotics in the ocular globus. Therapeutic implications].
    García E; Mensa J; Martínez JA
    Rev Esp Quimioter; 2001 Dec; 14(4):331-9. PubMed ID: 11856978
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicity of intravitreal injections of antibiotics and antivirals].
    Libert J
    Bull Soc Belge Ophtalmol; 2007; (304):89-97. PubMed ID: 17718233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye.
    Stern WH; Heath TD; Lewis GP; Guerin CJ; Erickson PA; Lopez NG; Hong KL
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):907-11. PubMed ID: 3032840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitrectomy in experimental endophthalmitis: Part I-Fungal infection.
    Huang K; Peyman GA; McGetrick J
    Ophthalmic Surg; 1979 Mar; 10(3):84-6. PubMed ID: 460810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin levels after intravitreal injection. Effects of inflammation and surgery.
    Aguilar HE; Meredith TA; el-Massry A; Shaarawy A; Kincaid M; Dick J; Ritchie DJ; Reichley RM; Neisman MK
    Retina; 1995; 15(5):428-32. PubMed ID: 8594637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitreous substitutes as drug release systems].
    Szurman P; Frank C; Kaczmarek RT; Spitzer MS
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):718-24. PubMed ID: 19750422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular injection of ceftazidime. Effects of inflammation and surgery.
    Shaarawy A; Meredith TA; Kincaid M; Dick J; Aguilar E; Ritchie DJ; Reichley RM
    Retina; 1995; 15(5):433-8. PubMed ID: 8594638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
    Liu F; Kwok AK; Cheung BM
    Curr Eye Res; 2008 Sep; 33(9):761-8. PubMed ID: 18798079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presumed macular toxicity of intravitreal antibiotics.
    Widmer S; Helbig H
    Klin Monbl Augenheilkd; 2006 May; 223(5):456-8. PubMed ID: 16705531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):151-9. PubMed ID: 100873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
    Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
    Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial agents in the treatment of ocular infections.
    Barza M
    Infect Dis Clin North Am; 1989 Sep; 3(3):533-51. PubMed ID: 2671138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of intravitreal antiviral drugs.
    Pulido JS; Palacio M; Peyman GA; Fiscella R; Greenberg D; Stelmack T
    Ophthalmic Surg; 1984 Aug; 15(8):666-9. PubMed ID: 6483372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of vitrectomy and intra-vitreous injections in the treatment of traumtic and iatrogenic endophthalmitis].
    Gribomont AC
    Bull Soc Belge Ophtalmol; 1996; 260():93-9. PubMed ID: 9026313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit.
    Dvorchik BH; Marquis JK
    Drug Metab Dispos; 2000 Oct; 28(10):1255-61. PubMed ID: 10997948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.